Federation des caisses Desjardins du Quebec’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-201,000	Closed	-$38.2K	–	2495
2023 Q2	$38.2K	Sell	201,000 -150,000	-43%	-$28.5K	﹤0.01%	1409
2023 Q1	$119K	Sell	351,000 -29,800	-8%	-$10.1K	﹤0.01%	1112
2022 Q4	$123K	Sell	380,800 -40,200	-10%	-$13K	﹤0.01%	1204
2022 Q3	$175K	Hold	421,000	–	–	﹤0.01%	1133
2022 Q2	$183K	Sell	421,000 -45,000	-10%	-$19.6K	﹤0.01%	1146
2022 Q1	$587K	Sell	466,000 -35,000	-7%	-$44.1K	0.01%	789
2021 Q4	$651K	Sell	501,000 -20,000	-4%	-$26K	0.01%	777
2021 Q3	$1.07M	Sell	521,000 -20,050	-4%	-$41.3K	0.01%	669
2021 Q2	$855K	Sell	541,050 -10,000	-2%	-$15.8K	0.01%	745
2021 Q1	$1.22M	Sell	551,050 -25,000	-4%	-$55.5K	0.01%	620
2020 Q4	$1.43M	Hold	576,050	–	–	0.02%	554
2020 Q3	$1.42M	Sell	576,050 -25,000	-4%	-$61.5K	0.02%	481
2020 Q2	$2.13M	Sell	601,050 -15,000	-2%	-$53.3K	0.03%	367
2020 Q1	$1.44M	Sell	616,050 -35,000	-5%	-$81.9K	0.03%	427
2019 Q4	$1.43M	Sell	651,050 -50,000	-7%	-$110K	0.02%	548
2019 Q3	$1.28M	Buy	701,050 +1,000	+0.1%	+$1.83K	0.02%	571
2019 Q2	$1.02M	Hold	700,050	–	–	0.01%	640
2019 Q1	$1.38M	Sell	700,050 -23,593	-3%	-$46.5K	0.02%	512
2018 Q4	$948K	Sell	723,643 -30,150	-4%	-$39.5K	0.02%	607
2018 Q3	$1.85M	Hold	753,793	–	–	0.03%	479
2018 Q2	$2.53M	Hold	753,793	–	–	0.04%	372
2018 Q1	$3.19M	Sell	753,793 -55,000	-7%	-$233K	0.05%	295
2017 Q4	$2.67M	Sell	808,793 -40,699	-5%	-$134K	0.04%	361
2017 Q3	$3.25M	Hold	849,492	–	–	0.05%	290
2017 Q2	$3.74M	Hold	849,492	–	–	0.06%	260
2017 Q1	$3.08M	Buy	+849,492	New	+$3.08M	0.06%	258